K Charles Janac Sells 4,583 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 4,583 shares of Arteris stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $7.24, for a total value of $33,180.92. Following the transaction, the chief executive officer now directly owns 310,758 shares in the company, valued at approximately $2,249,887.92. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

K Charles Janac also recently made the following trade(s):

• On Wednesday, July 3rd, K Charles Janac sold 9,168 shares of Arteris stock. The stock was sold at an average price of $7.23, for a total transaction of $66,284.64.
• On Tuesday, June 4th, K Charles Janac sold 3,303 shares of Arteris stock. The stock was sold at an average price of $7.70, for a total transaction of $25,433.10.

Arteris Stock Performance

Shares of AIP opened at $7.21 on Friday. The firm has a market cap of $277.44 million, a price-to-earnings ratio of -7.00 and a beta of 1.11. The company’s fifty day moving average is $7.83 and its 200-day moving average is $6.96. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.11. Arteris, Inc. has a 12 month low of $4.20 and a 12 month high of $9.54.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Thursday, May 2nd. The company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.03. Arteris had a negative net margin of 69.70% and a negative return on equity of 198.35%. The firm had revenue of $12.95 million during the quarter, compared to analysts’ expectations of $12.60 million. Equities analysts expect that Arteris, Inc. will post -0.91 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Jefferies Financial Group reaffirmed a “hold” rating and issued a $9.00 price target (down from $11.00) on shares of Arteris in a research note on Monday, May 13th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 target price on shares of Arteris in a research report on Friday, May 3rd. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Arteris has an average rating of “Moderate Buy” and a consensus target price of $13.40.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Acuitas Investments LLC boosted its position in Arteris by 150.3% during the fourth quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock worth $1,272,000 after purchasing an additional 129,692 shares during the period. Worth Venture Partners LLC lifted its stake in shares of Arteris by 114.3% in the fourth quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock worth $647,000 after buying an additional 58,620 shares during the last quarter. Citigroup Inc. bought a new stake in shares of Arteris during the 3rd quarter worth $363,000. Federated Hermes Inc. grew its stake in Arteris by 8.3% in the 3rd quarter. Federated Hermes Inc. now owns 130,000 shares of the company’s stock valued at $846,000 after buying an additional 10,000 shares during the last quarter. Finally, Algert Global LLC bought a new position in Arteris in the 3rd quarter worth $142,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.